These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 3332284)

  • 1. Topical ocular drug delivery: recent developments and future challenges.
    Lee VH; Robinson JR
    J Ocul Pharmacol; 1986; 2(1):67-108. PubMed ID: 3332284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular preparations: the formulation approach.
    Kaur IP; Kanwar M
    Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
    Jiao J
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical and systemic drug delivery to the posterior segments.
    Hughes PM; Olejnik O; Chang-Lin JE; Wilson CG
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2010-32. PubMed ID: 16289435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Topical Ocular Drug Delivery.
    Yellepeddi VK; Palakurthi S
    J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in ocular drug delivery.
    Chen H
    J Drug Target; 2015; 23(7-8):597-604. PubMed ID: 26453157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarriers for ocular drug delivery: Recent advances and future opportunities.
    Amrutkar CS; Patil SB
    Indian J Ophthalmol; 2023 Jun; 71(6):2355-2366. PubMed ID: 37322644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming ocular drug delivery barriers through the use of physical forces.
    Huang D; Chen YS; Rupenthal ID
    Adv Drug Deliv Rev; 2018 Feb; 126():96-112. PubMed ID: 28916492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesicular systems in ocular drug delivery: an overview.
    Kaur IP; Garg A; Singla AK; Aggarwal D
    Int J Pharm; 2004 Jan; 269(1):1-14. PubMed ID: 14698571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An updated patent review on ocular drug delivery systems with potential for commercial viability.
    Srivastava R; Pathak K
    Recent Pat Drug Deliv Formul; 2011 May; 5(2):146-62. PubMed ID: 21453249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits.
    Chetoni P; Burgalassi S; Monti D; Tampucci S; Tullio V; Cuffini AM; Muntoni E; Spagnolo R; Zara GP; Cavalli R
    Eur J Pharm Biopharm; 2016 Dec; 109():214-223. PubMed ID: 27789355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical delivery of ocular therapeutics: carrier systems and physical methods.
    Souza JG; Dias K; Pereira TA; Bernardi DS; Lopez RF
    J Pharm Pharmacol; 2014 Apr; 66(4):507-30. PubMed ID: 24635555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye.
    Wang Y; Xu X; Gu Y; Cheng Y; Cao F
    Expert Opin Drug Deliv; 2018 Jul; 15(7):687-701. PubMed ID: 29985660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review on recent drug delivery systems for posterior segment of eye.
    Nayak K; Misra M
    Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
    Lakhani P; Patil A; Majumdar S
    Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular drug delivery.
    Ghate D; Edelhauser HF
    Expert Opin Drug Deliv; 2006 Mar; 3(2):275-87. PubMed ID: 16506953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.
    Souto EB; Doktorovova S; Gonzalez-Mira E; Egea MA; Garcia ML
    Curr Eye Res; 2010 Jul; 35(7):537-52. PubMed ID: 20597640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery systems for the eye.
    Kearns VR; Williams RL
    Expert Rev Med Devices; 2009 May; 6(3):277-90. PubMed ID: 19419285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Emphasizing the research for ocular drug delivery system].
    Chen ZJ
    Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):292-5. PubMed ID: 16762202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.